Latest News and Press Releases

27 MARCH 2025                PRESS RELEASE Urteste plans to start clinical trials for its pancreatic cancer test in Europe in Q3 2025 Gdańsk, Poland – 27 March 2025 – Urteste S.A. (Warsaw Stock...

Rockville, MD, March 11, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global breast cancer diagnostics market is estimated to reach a...

Vara's PRAIM study shows AI boosts breast cancer detection by 17.6% in German screening of 500,000 participants; cutting radiologist workloads by 43%

Vara, the healthcare technology company revolutionizing breast cancer screening with AI, raises $8.9M in funding

               Urteste Expands Development of Innovative Diagnostic Projects Gdańsk, Poland – 26 SEPTEMBER 2024, 16:00 CET - Urteste S.A. (Warsaw Stock Exchange: URT),  a biotechnology company...

28 MAY 2024        PRESS RELEASE Urteste has successfully developed a prototype urine-based diagnostic test for detecting brain tumours Gdańsk, Poland – 28 MAY 2024, Urteste S.A. (Warsaw Stock...

New York, Jan. 24, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the Liquid Biopsy Market size is projected to exceed USD 35.3 Billion by 2033, with a promising CAGR of 13.1% from 2024 to 2033. ...

London, Dec. 13, 2023 (GLOBE NEWSWIRE) -- The global multi-cancer early detection market, presently valued at approximately US$0.89 Bn, is projected to witness an impressive CAGR of 16.3% through...

New York, NY, Jan. 25, 2023 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (the “Company”) (Nasdaq: ANPC), a biotechnology company with operations in the United States and China focused on...

Sandy, USA, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Multi Cancer Early Detection Market Size, Trends and Insights By Type (Liquid Biopsy,...